gene_name_1,gene_name_2,co_occurrence
VEGFR-2,VEGF-A,2
VEGFR-2,VEGFR-3,1
VEGFR-2,PDGFR,1
VEGFR-2,FMS proto-oncogene-like tyrosine kinase 3,1
VEGFR-2,HIF1alpha,1
VEGFR-2,RET,1
VEGFR-2,platelet-derived growth factor receptor,1
VEGFR-2,FLT1,2
VEGFR-2,receptor tyrosine kinase proto-oncogene,1
VEGFR-2,FLT3,1
VEGFR-2,FMS-like tyrosine kinase 1,1
VEGFR-2,C-KIT,1
VEGFR-2,KDR,2
VEGFR-2,fetal liver kinase-1,1
VEGFR-2,VEGF,2
VEGFR-2,VEGFR-1,2
VEGFR-2,Flk-1,1
VEGFR-2,HIF2alpha,1
VEGFR-2,kinase insert domain protein receptor,1
pVHL,von Hippel-Lindau,1
pVHL,VHL,1
VEGF-A,VEGFR-3,1
VEGF-A,FLT1,2
VEGF-A,FMS-like tyrosine kinase 1,1
VEGF-A,KDR,2
VEGF-A,fetal liver kinase-1,1
VEGF-A,VEGF,2
VEGF-A,VEGFR-1,2
VEGF-A,Flk-1,1
VEGF-A,kinase insert domain protein receptor,1
ANG1,VEGFA,1
ANG1,IL-8,1
ANG1,thrombospondin-1,1
ANG1,placental growth factor,1
ANG1,PlGF,1
ANG1,angiopoietin-1,1
MMP-9,IL-1 RA,1
MMP-9,HIF-1alpha,1
MMP-9,VEGF,1
MMP-9,CA IX,1
MMP-9,IL-1 receptor antagonist,1
VEGFR-3,PDGFR,1
VEGFR-3,FMS proto-oncogene-like tyrosine kinase 3,1
VEGFR-3,RET,1
VEGFR-3,platelet-derived growth factor receptor,1
VEGFR-3,receptor tyrosine kinase proto-oncogene,1
VEGFR-3,FLT3,1
VEGFR-3,C-KIT,1
VEGFR-3,FLT4,2
VEGFR-3,VEGF-C and D,2
VEGFR-3,PDGF-B,1
VEGFA,IL-8,1
VEGFA,thrombospondin-1,1
VEGFA,BNIP3,1
VEGFA,CA9,1
VEGFA,placental growth factor,1
VEGFA,GLUT1,1
VEGFA,PlGF,1
VEGFA,angiopoietin-1,1
soluble VEGFR 2,VEGFR,1
soluble VEGFR 2,sVEGFR-2,1
soluble VEGFR 2,VEGF,1
TSC2,LKB1,1
TSC2,PTEN,1
TSC2,TSC1,1
IL-8,thrombospondin-1,1
IL-8,placental growth factor,1
IL-8,VEGF,1
IL-8,PlGF,1
IL-8,angiopoietin-1,1
PDGFR,VEGFR,1
PDGFR,FMS proto-oncogene-like tyrosine kinase 3,1
PDGFR,RET,1
PDGFR,platelet-derived growth factor receptor,1
PDGFR,receptor tyrosine kinase proto-oncogene,1
PDGFR,FLT3,1
PDGFR,C-KIT,2
PDGFR,FLT-3,1
VEGFR,sVEGFR-2,2
VEGFR,RET,1
VEGFR,EGFR,2
VEGFR,C-KIT,1
VEGFR,VEGF,4
VEGFR,FLT-3,1
VEGFR3,VEGFR1,1
VEGFR3,VEGFR2,1
VEGFR3,VEGF,1
HIF-2alpha,von Hippel-Lindau,1
HIF-2alpha,vascular endothelial growth factor,1
HIF-2alpha,VHL,1
HIF-2alpha,HIF-1alpha,2
HIF-2alpha,hypoxia-inducible factor 1alpha,1
HIF-2alpha,VEGF,1
Akt,hypoxia inducible factor-1alpha,1
Akt,VEGF,1
von Hippel-Lindau,vascular endothelial growth factor,1
von Hippel-Lindau,VHL,2
hypoxia-inducible factor 1,HIF-1,1
FMS proto-oncogene-like tyrosine kinase 3,RET,1
FMS proto-oncogene-like tyrosine kinase 3,platelet-derived growth factor receptor,1
FMS proto-oncogene-like tyrosine kinase 3,receptor tyrosine kinase proto-oncogene,1
FMS proto-oncogene-like tyrosine kinase 3,FLT3,1
FMS proto-oncogene-like tyrosine kinase 3,C-KIT,1
thrombospondin-1,placental growth factor,1
thrombospondin-1,PlGF,1
thrombospondin-1,angiopoietin-1,1
TSC1/2,LKB1,1
TSC1/2,PTEN,1
HIF1alpha,HIF3alpha,1
HIF1alpha,carbonic anhydrase IX,1
HIF1alpha,VEGF,1
HIF1alpha,HIF2alpha,5
HIF1alpha,CA IX,1
sVEGFR-2,VEGF,2
VEGFR1,VEGFR2,1
VEGFR1,VEGF,1
RET,EGFR,1
RET,platelet-derived growth factor receptor,1
RET,receptor tyrosine kinase proto-oncogene,1
RET,FLT3,1
RET,C-KIT,1
BNIP3,CA9,1
BNIP3,GLUT1,1
EGFR,phosphatase and tensin homologue,2
EGFR,PTEN,2
EGFR,VEGF,4
EGFR,KRAS,3
LKB1,mTOR,2
LKB1,PTEN,4
LKB1,VEGF,2
LKB1,TSC1,1
CA9,GLUT1,1
mammalian target of rapamycin,mTOR,2
mammalian target of rapamycin,hypoxia-inducible factor 1alpha,1
mammalian target of rapamycin,VEGF,1
platelet-derived growth factor receptor,receptor tyrosine kinase proto-oncogene,1
platelet-derived growth factor receptor,FLT3,1
platelet-derived growth factor receptor,C-KIT,1
HIF3alpha,HIF2alpha,1
phosphatase and tensin homologue,PTEN,2
phosphatase and tensin homologue,VEGF,2
phosphatase and tensin homologue,KRAS,2
hypoxia inducible factor-1alpha,BRAF,1
hypoxia inducible factor-1alpha,VEGF,1
FLT1,FMS-like tyrosine kinase 1,1
FLT1,KDR,2
FLT1,fetal liver kinase-1,1
FLT1,VEGF,1
FLT1,VEGFR-1,2
FLT1,Flk-1,1
FLT1,kinase insert domain protein receptor,1
vascular endothelial growth factor,VHL,1
vascular endothelial growth factor,hypoxia-inducible factor-1alpha,1
vascular endothelial growth factor,Flt-1,1
receptor tyrosine kinase proto-oncogene,FLT3,1
receptor tyrosine kinase proto-oncogene,C-KIT,1
IL-1 RA,IL-1 receptor antagonist,1
hypoxia-inducible factor-1alpha,hypoxia-inducible factor-2alpha,1
placental growth factor,PlGF,1
placental growth factor,angiopoietin-1,1
FLT3,C-KIT,1
FMS-like tyrosine kinase 1,KDR,1
FMS-like tyrosine kinase 1,fetal liver kinase-1,1
FMS-like tyrosine kinase 1,VEGFR-1,1
FMS-like tyrosine kinase 1,Flk-1,1
FMS-like tyrosine kinase 1,kinase insert domain protein receptor,1
C-KIT,FLT-3,1
carbonic anhydrase IX,CA IX,1
VEGFR2,VEGF,1
KDR,fetal liver kinase-1,1
KDR,VEGF,1
KDR,VEGFR-1,2
KDR,Flk-1,1
KDR,kinase insert domain protein receptor,1
mTOR,PTEN,2
mTOR,VEGF,5
mTOR,HIF1,1
HIF-1alpha,hypoxia-inducible factor 1alpha,1
HIF-1alpha,VEGF,1
HIF-1alpha,CA IX,1
PTEN,VEGF,4
PTEN,KRAS,2
PTEN,TSC1,1
FLT4,VEGF-C and D,2
fetal liver kinase-1,VEGFR-1,1
fetal liver kinase-1,Flk-1,1
fetal liver kinase-1,kinase insert domain protein receptor,1
VEGF,VEGFR-1,1
VEGF,HIF2alpha,1
VEGF,CA IX,1
VEGF,KRAS,2
PlGF,angiopoietin-1,1
VEGFR-1,Flk-1,1
VEGFR-1,kinase insert domain protein receptor,1
intracellular cell adhesion molecule-1,ICAM-1,1
Flk-1,kinase insert domain protein receptor,1
KRAS,TSC1,1
